2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5 Remdesivir Entèmedyè COVID-19
Manifakti Komèsyal Pwovizyon pou Remdesivir ak entèmedyè ki gen rapò ak kalite siperyè
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilil Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolit (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Entèmedyè CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine CAS 937046-98-5
Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine CAS 159326-68-8
4-Amino-7-yodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Non Chimik | 2,3,5-Tri-O-benzyl-D-ribonolactone |
Sinonim | 2,3,5-Tri-O-Benzyl-D-Ribono-1,4-Lactone;Remdesivir Entèmedyè |
Nimewo CAS | 55094-52-5 |
Nimewo CAT | RF-PI301 |
Estati Stock | Nan stock, pwodiksyon echèl jiska dè santèn de kilogram |
Fòmil molekilè | C26H26O5 |
Pwa molekilè | 418.49 |
Pwen k ap fonn | 54.0-55.0℃ |
Kondisyon Depo | Tanperati chanm |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Solid jòn oswa blan |
Solibilite | Soluble nan CH2Cl2 ak ensolubl nan H2O |
RMN ak MS | Ta dwe Konfòme |
Idantifikasyon | IR ak TLC |
Imidite | ≤1.0% |
Rezid sou ignisyon | ≤0.50% |
Nenpòt enpurte endividyèl | ≤0.50% |
Metal lou | ≤50ppm |
HPLC (210nm) | ≥99.0% |
HPLC (ELSD) | ≥99.0% |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Remdesivir (CAS 1809249-37-3) |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
2,3,5-Tri-O-benzyl-D-ribonolactone (CAS 55094-52-5) se yon entèmedyè Remdesivir.Remdesivir (CAS 1809249-37-3) se yon nouvo dwòg antiviral nan klas analogue nukleotid, yo itilize nan tretman COVID-19.Remdesivir (GS-5734) se yon nouvo analogue nukleozid antiviral ki anpeche viris epatit murin (MHV) ak EC50 ki sanble ak SARS-CoV ak MERS-CoV.Coronavirus (CoVs) se viris RNA ki gen yon sèl-sans pozitif, ki enfekte yon pakèt bèt bèt.Nan imen, CoV yo te rekonèt kòm tipikman lakòz rim sèvo ak nemoni jiskaske Aparisyon kowonaviris sendwòm respiratwa egi grav (SARS-CoV) an 2002 ak kowonaviris sendwòm respiratwa Mwayen Oryan (MERS-CoV) nan 2012 nan sous zoonotik.Remdesivir se prodrog monofosforamidat nan analogue nukleozid C-adenosine GS-441524.Nan selil timè nan sèvo reta (DBT) ki enfekte ak MHV, GS-5734 inibit MHV pi plis pase GS-441524, ak yon GS-5734 EC50 nan 0.03 M. Anplis de sa, valè EC50 yo te detèmine apre tretman ak GS-441524 ak GS-5734. nan kilti prensipal selil epitelyal moun (HAE) ki enfekte ak SARS-CoV- ak MERS-CoV.